Page 2 - Pieris Architects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pieris architects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pieris Architects Today - Breaking & Trending Today

David Pieris Group enters renewable energy industry with solar solutions - Business

Dailymirror.lk – Sri Lanka 24 Hours Online Breaking News : News, Politics, Video, Finance, Business, Sports, Entertainment, Travel, sri lanka news,sri lanka latest news, latest breaking news, latest political news, covid-19 news,covid-19 news sri lanka, Sri Lanka Coronavirus updates, sl news, sl covid-19 news, SL breaking news, daily news, breaking news in sri lanka ....

Sanath Sujeewa , David Pieris Solar Energy , David Pieris Group , Pieris Solar Energy , David Pieris Solar Energy Chief Engineer , Assistant General Manager Sanath Sujeewa , David Pieris , Ri Lanka , Sri Lanka News , Ailymirror , Daily Mirror , Ailymirror Lk , Ews , Reaking News , Sri Lanka News , Anka News , Ri Lanka Cricket , Ri Lanka Breaking News , Epal Earthquake , Xchange Rates ,

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Encouraging Preclinical Data for PRS-400 at ATS 2023 International Conference

BOSTON, MA / ACCESSWIRE / May 22, 2023 / Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology ....

United States , The Notch , Gewinn Nur , Joe Patneaude , Shane Olwill , International Conference , American Thoracic Society , Pieris Pharmaceuticals Inc View , Exchange Commission , Company Quarterly Reports On Form , Securities Exchange , Pieris Pharmaceuticals , Pieris Pharmaceuticals Inc , Chief Development Officer , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Relations Contact , Inc View ,

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Promising Preclinical Data for PRS-220 at ATS 2023 International Conference

BOSTON, MA / ACCESSWIRE / May 21, 2023 / Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology ....

District Of Columbia , United States , Joe Patneaude , Gewinn Nur , Pieris Pharmaceuticals , American Thoracic Society , Pieris Pharmaceuticals Inc , Company Quarterly Reports On Form , Pieris Pharmaceuticals Inc View , International Conference , Securities Exchange , Exchange Commission , Chief Development Officer , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Relations Contact , Inc View ,

Pieris Pharmaceuticals: Q1 Earnings Snapshot

BOSTON — BOSTON — Pieris Pharmaceuticals Inc. on Wednesday reported a loss of $13.2 million in its first quarter.
The Boston-based company said it had a loss of 18 cents per. | May 10, 2023 ....

United States , Zacks Investment Research , Pieris Pharmaceuticals Inc , Automated Insights , Pieris Pharmaceuticals , Nc Stock Exchange , Press Release , Ents Pirs Us7207951036 ,

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals to Host First Quarter 2023 Investor Call and Provide Corporate Update on May 10, 2023

BOSTON, MA / ACCESSWIRE / May 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology ....

United States , Joe Patneaude , Pieris Pharmaceuticals Inc , Pieris Pharmaceuticals Inc View , Pieris Pharmaceuticals , Toll Free , Relations Contact , Inc View ,